Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation
- 1 March 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 355 (9208) , 956-962
- https://doi.org/10.1016/s0140-6736(00)90012-6
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Antithrombotic Therapy To Prevent Stroke in Patients with Atrial FibrillationAnnals of Internal Medicine, 1999
- Prevalence of atrial fibrillation and eligibility for anticoagulants in the communityThe Lancet, 1998
- Decision Analysis in the Selection, Design and Application of Clinical and Health Services ResearchJournal of Health Services Research & Policy, 1998
- Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatmentBMJ, 1998
- Population based study of use of anticoagulants among patients with atrial fibrillation in the communityBMJ, 1997
- An evidence based approach to individualising treatmentBMJ, 1995
- Making Decisions About Antithrombotic Therapy in Heart DiseaseChest, 1995
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993
- Practice Guidelines, a New Reality in MedicineArchives of internal medicine (1960), 1992
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991